A new lab-designed molecule that exploits a weakness in cells can kill a wide range of cancers that are difficult to treat, including triple-negative breast cancer, pancreatic and ovarian cancers, as well as glioblastoma, according to a new U.S. study conducted on human cancer tissue and in human cancers grown in mice.
/PRNewswire/ A scientific team, led by the scientific founders of EtiraRx, has identified a small molecule, ERX-41, as a novel oral therapeutic agent that.